Magel2, a Prader-Willi syndrome candidate gene, modulates the activities of circadian rhythm proteins in cultured cells

Journal of Circadian Rhythms

Volumn 9, Issue , 2011, Pages

  Devos, Julia ^a   Weselake, Sara V ^a   Wevrick, Rachel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Luciferase assay; Melanoma antigen gene; Necdin; Prader willi syndrome; Suprachiasmatic nucleus

Indexed keywords

MAGEL2 PROTEIN; PEPTIDES AND PROTEINS; PER2 PROTEIN; PROTEIN BMAL1; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STRAIN 3T3; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; PRADER WILLI SYNDROME; PROTEIN PROTEIN INTERACTION;

EID: 84855164429     PISSN: None     EISSN: 17403391     Source Type: Journal    
DOI: 10.1186/1740-3391-9-12     Document Type: Article

References (42)

1. Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet 2009, 17:3-13. 10.1038/ejhg.2008.165, 2985966, 18781185.
2. Lee S, Kozlov S, Hernandez L, Chamberlain SJ, Brannan CI, Stewart CL, Wevrick R. Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype. Hum Mol Genet 2000, 9:1813-1819. 10.1093/hmg/9.12.1813, 10915770.
3. Boccaccio I, Glatt-Deeley H, Watrin F, Roeckel N, Lalande M, Muscatelli F. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum Mol Genet 1999, 8:2497-2505. 10.1093/hmg/8.13.2497, 10556298.
4. Camfferman D, McEvoy RD, O'Donoghue F, Lushington K. Prader Willi Syndrome and excessive daytime sleepiness. Sleep Med Rev 2008, 12:65-75. 10.1016/j.smrv.2007.08.005, 18201664.
5. Lee S, Walker CL, Wevrick R. Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain. Gene Expr Patterns 2003, 3:599-609. 10.1016/S1567-133X(03)00113-3, 12971993.
6. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002, 109:307-320. 10.1016/S0092-8674(02)00722-5, 12015981.
7. Kozlov SV, Bogenpohl JW, Howell MP, Wevrick R, Panda S, Hogenesch JB, Muglia LJ, Van Gelder RN, Herzog ED, Stewart CL. The imprinted gene Magel2 regulates normal circadian output. Nat Genet 2007, 39:1266-1272. 10.1038/ng2114, 17893678.
8. Miller BH, Olson SL, Turek FW, Levine JE, Horton TH, Takahashi JS. Circadian clock mutation disrupts estrous cyclicity and maintenance of pregnancy. Curr Biol 2004, 14:1367-1373. 10.1016/j.cub.2004.07.055, 15296754.
9. Mercer RE, Wevrick R. Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice. PLoS One 2009, 4:e4291. 10.1371/journal.pone.0004291, 2627930, 19172181.
10. Tennese AA, Wevrick R. Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice. Endocrinology 2011, 152:967-978. 10.1210/en.2010-0709, 21248145.
11. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006, 15(Spec No 2):R271-277.
12. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 2001, 107:855-867. 10.1016/S0092-8674(01)00610-9, 11779462.
13. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008, 9:764-775. 10.1038/nrg2430, 18802415.
14. Siepka SM, Yoo SH, Park J, Song W, Kumar V, Hu Y, Lee C, Takahashi JS. Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell 2007, 129:1011-1023. 10.1016/j.cell.2007.04.030, 17462724.
15. Shirogane T, Jin J, Ang XL, Harper JW. SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein. J Biol Chem 2005, 280:26863-26872. 10.1074/jbc.M502862200, 15917222.
16. Young MW, Kay SA. Time zones: a comparative genetics of circadian clocks. Nat Rev Genet 2001, 2:702-715. 10.1038/35088576, 11533719.
17. Barker PA, Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 2002, 67:705-712. 10.1002/jnr.10160, 11891783.
18. Sasaki A, Hinck L, Watanabe K. RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins. J Recept Signal Transduct Res 2005, 25:181-198. 10.1080/10799890500210511, 16194933.
19. Moon HE, Ahn MY, Park JA, Min KJ, Kwon YW, Kim KW. Negative regulation of hypoxia inducible factor-1alpha by necdin. FEBS Lett 2005, 579:3797-3801. 10.1016/j.febslet.2005.05.072, 15978586.
20. Friedman ER, Fan CM. Separate necdin domains bind ARNT2 and HIF1alpha and repress transcription. Biochem Biophys Res Commun 2007, 363:113-118. 10.1016/j.bbrc.2007.08.108, 2083645, 17826745.
21. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, Schibler U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008, 134:317-328. 10.1016/j.cell.2008.06.050, 18662546.
22. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, Guarente LP, Sassone-Corsi P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340. 10.1016/j.cell.2008.07.002, 18662547.
23. Hasegawa K, Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci 2008, 28:8772-8784. 10.1523/JNEUROSCI.3052-08.2008, 18753379.
24. Jordan BW, Dinev D, LeMellay V, Troppmair J, Gotz R, Wixler L, Sendtner M, Ludwig S, Rapp UR. Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem 2001, 276:39985-39989. 10.1074/jbc.C100171200, 11546791.
25. Sasaki A, Masuda Y, Iwai K, Ikeda K, Watanabe K. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J Biol Chem 2002, 277:22541-22546. 10.1074/jbc.M109728200, 11959851.
26. Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 2010, 39:963-974. 10.1016/j.molcel.2010.08.029, 20864041.
27. Feng Y, Gao J, Yang M. When MAGE meets RING: insights into biological functions of MAGE proteins. Protein Cell 2011, 2:7-12. 10.1007/s13238-011-1002-9, 21337005.
28. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 437:1173-1178. 10.1038/nature04209, 16189514.
29. Di Certo MG, Corbi N, Bruno T, Iezzi S, De Nicola F, Desantis A, Ciotti MT, Mattei E, Floridi A, Fanciulli M, Passananti C. NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J Cell Sci 2007, 120:1852-1858. 10.1242/jcs.03454, 17488777.
30. Paltoglou S, Roberts BJ. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases. Oncogene 2007, 26:604-609. 10.1038/sj.onc.1209818, 16862177.
31. Bush JR, Wevrick R. The Prader-Willi syndrome protein necdin interacts with the E1A-like inhibitor of differentiation EID-1 and promotes myoblast differentiation. Differentiation 2008, 76:994-1005.
32. Lee S, Walker CL, Karten B, Kuny SL, Tennese AA, O'Neill MA, Wevrick R. Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum Mol Genet 2005, 14:627-637. 10.1093/hmg/ddi059, 15649943.
33. Maeda Y, Suzuki T, Pan X, Chen G, Pan S, Bartman T, Whitsett JA. CUL2 is required for the activity of hypoxia-inducible factor and vasculogenesis. J Biol Chem 2008, 283:16084-16092. 10.1074/jbc.M710223200, 2414293, 18372249.
34. Wang X, Tang J, Xing L, Shi G, Ruan H, Gu X, Liu Z, Wu X, Gao X, Xu Y. Interaction of MAGED1 with nuclear receptors affects circadian clock function. EMBO J 2010, 29:1389-1400. 10.1038/emboj.2010.34, 2868574, 20300063.
35. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, Hastings MH, Reppert SM. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999, 98:193-205. 10.1016/S0092-8674(00)81014-4, 10428031.
36. Kondratov RV, Chernov MV, Kondratova AA, Gorbacheva VY, Gudkov AV, Antoch MP. BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev 2003, 17:1921-1932. 10.1101/gad.1099503, 196247, 12897057.
37. Kwon I, Lee J, Chang SH, Jung NC, Lee BJ, Son GH, Kim K, Lee KH. BMAL1 shuttling controls transactivation and degradation of the CLOCK/BMAL1 heterodimer. Mol Cell Biol 2006, 26:7318-7330. 10.1128/MCB.00337-06, 1592876, 16980631.
38. Yoo SH, Ko CH, Lowrey PL, Buhr ED, Song EJ, Chang S, Yoo OJ, Yamazaki S, Lee C, Takahashi JS. A noncanonical E-box enhancer drives mouse Period2 circadian oscillations in vivo. Proc Natl Acad Sci USA 2005, 102:2608-2613. 10.1073/pnas.0409763102, 548324, 15699353.
39. Tamanini F, Yagita K, Okamura H, van der Horst GT. Nucleocytoplasmic shuttling of clock proteins. Methods Enzymol 2005, 393:418-435.
40. Lee H, Chen R, Lee Y, Yoo S, Lee C. Essential roles of CKIdelta and CKIepsilon in the mammalian circadian clock. Proc Natl Acad Sci USA 2009, 106:21359-21364. 10.1073/pnas.0906651106, 2795500, 19948962.
41. Gatfield D, Schibler U. Physiology. Proteasomes keep the circadian clock ticking. Science 2007, 316:1135-1136. 10.1126/science.1144165, 17495136.
42. Zhang EE, Kay SA. Clocks not winding down: unravelling circadian networks. Nat Rev Mol Cell Biol 2010, 11:764-776. 10.1038/nrm2995, 20966970.